Skip to main content

Advertisement

SpringerLink
Log in

Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria

  • Pharmacodynamics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

The aim of this open-labelled, randomised, parallel-group study was to evaluate the effect of long-term monotherapy with manidipine or lisinopril on albumin excretion rate (AER) and left ventricular mass index (LVMI) in hypertensive patients with type-2 diabetes and microalbuminuria.

Methods

After a 4-week wash-out period, 174 patients with essential hypertension [diastolic blood pressure (DBP) >80 mmHg and <100 mmHg], type-2 diabetes and microalbuminuria were randomised to manidipine 10 mg o.d. or lisinopril 10 mg o.d.; after 8 weeks, the dose was doubled in non-responders (DBP >80 mmHg); after 3 months, treatment was discontinued in the non-responder patients and in those complaining of side effects; the remaining 121 patients continued their therapy with manidipine or lisinopril, and 99 completed the 2-year study. At the end of the wash-out period, of the titration period and after 6, 12, 18 and 24 months of treatment, BP was measured, AER, creatinine clearance, glycosylated haemoglobin (HbA1c) and body mass index (BMI) were evaluated and an echocardiographic evaluation was performed.

Results

The 99 patients who completed the study were statistically analysed according to a per-protocol evaluation. Manidipine and lisinopril significantly reduced systolic blood pressure (SBP) and DBP levels (at 24 months, −22.3/15.5 mmHg, P<0.001 versus baseline and −21.4/15.7 mmHg, P<0.01 versus baseline, respectively). Both drugs provided a significant decrease in AER, but it was significantly more pronounced with lisinopril (at 24 weeks, −37.2 mg/24 h, P<0.001 versus baseline) than with manidipine (–29.9 mg/24 h, P<0.05 versus baseline) and became evident earlier in the lisinopril group (after 3 months versus 6 months of treatment). Manidipine produced a greater reduction of LVMI than lisinopril (−14.9 g/m2 versus –10.8 g/m2 at 24 months). The effect was more pronounced in patients with left ventricular hypertrophy at baseline (−19.8 g/m2 versus –12.8 g/m2, P<0.05).

Conclusion

These data suggest that, despite similar BP lowering, non-haemodynamic factors play an important role in the pharmacological reduction of AER and LVMI in diabetic hypertensive patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Agardh CD, Garcia-Puig J, Charbonnel B, Angelkort B, Barnett AH (1996) Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine. J Hum Hypertens 10:185–192

    CAS  PubMed  Google Scholar 

  2. Amann K, Irzyenic T, Mall G, Ritz E (1993) The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy: a stereological study. J Hypertens 11:969–975

    CAS  PubMed  Google Scholar 

  3. Brown RA, Lee MM, Sundareson AM, Woodbury DJ, Savage AO (1996) Influence of calcium channel blocker treatment on the mechanical properties of diabetic rat myocardium. Acta Diabetol 33:7–14

    CAS  PubMed  Google Scholar 

  4. Chan JCN, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R (1992) Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one-year analysis. BMJ 305:981–985

    CAS  PubMed  Google Scholar 

  5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright Jr, Roccella EJ (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The JNC 7 report. JAMA 289:2560–2572

    CAS  PubMed  Google Scholar 

  6. Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G (2004) Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive type 2 diabetic patients with microalbuminuria:DIAL Study (Diabete, Ipertensione, Albuminuria, Lercanidipina). Diab Nutr Metab 17:259–266

    CAS  Google Scholar 

  7. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man Anatomic validation of the method. Circulation 55:613–618

    CAS  PubMed  Google Scholar 

  8. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I (1986) Echocardiographic assessment of left ventricular hypertrophy. Comparison to necropsy findings. Am J Cardiol 57:450–458

    CAS  PubMed  Google Scholar 

  9. Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. Arch Intern Med 157:1413–1418

    CAS  PubMed  Google Scholar 

  10. Epstein M (1997) Diabetes and hypertension: the bad companions. J Hypertens 15(Suppl 2):S55–S62

    CAS  Google Scholar 

  11. Fogari R, Zoppi A, Malamani GD, Lusardi P, Destro M, Corradi L (1996) Effects of amlodipine vs enalapril on microalbuminuria in hypertensive patients with type 2 diabetes. Clin Drug Invest 11(Suppl):42–49

    Google Scholar 

  12. Fogari R, Zoppi A, Corradi L, Poletti L, Pasotti M, Fogari E, Mugellini A (2000) Long-term effects of amlodipine versus fosinopril on microalbuminuria in elderly hypertensive patients with type 2 diabetes mellitus. Curr Ther Res 61:163–173

    CAS  Google Scholar 

  13. Gerritsen TA, Bak AA, Stolk RP, Jonker JJC, Grobbee DE (1998) Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension. J Hypertens 16:689–696

    CAS  PubMed  Google Scholar 

  14. Hayashi K, Ozawa Y, Fujiwara K, Wakino S, Kumagai H, Saruta T (2003) Role of action of Calcium antagonists on efferent arterioles with special reference to glomerular hypertension. Am J Nephrol 23: 229–244

    CAS  PubMed  Google Scholar 

  15. IImura O, Shimamoto K (1993) Efficacy and mode of action of manidipine: a new calcium antagonist. Am Heart J 125:635–641

    CAS  PubMed  Google Scholar 

  16. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S (1994) Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 45:1637–1647

    CAS  PubMed  Google Scholar 

  17. Lancaster SG, Todd PA (1988) Lisinopril: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure. Drugs 35:646–669

    CAS  PubMed  Google Scholar 

  18. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic complications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566

    CAS  PubMed  Google Scholar 

  19. Lithel HOL (1991) Effect of antihypertensive drugs on insulin, glucose and lipid metabolism. Diab Care 14:203–209

    Google Scholar 

  20. Marban E, Koretsune Y (1990) Cell calcium, oncogenes and hypertrophy. Hypertension 15:652–658

    CAS  PubMed  Google Scholar 

  21. Martinez-Martin FJ, Saiz-Satjes M (2004) Addition of manidipine in type 2 diabetic patients with uncontrolled hypertension and microalbuminuria: the Amandha trial. J Hypertens 22(Suppl 2):S245

    Google Scholar 

  22. Messerli FH (1999) Combinations in the treatment of hypertension. ACE-inhibitors and Ca-antagonists. Am J Hypertens 12:86S–90S

    CAS  PubMed  Google Scholar 

  23. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 310:356–360

    CAS  PubMed  Google Scholar 

  24. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215–228

    CAS  PubMed  Google Scholar 

  25. Morelli E, Loon N, Meyer T, Peters W, Myers BD (1990) Effects of convertine enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39:76–82

    CAS  PubMed  Google Scholar 

  26. Nielsen FS, Ali S, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, Kastrup J, Parving HH (1997) Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathy. Diab Med 14:538–546

    CAS  Google Scholar 

  27. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, Kitzman DW, Hopkins PN, Morgan D, Rao DC, Devereux RB (2001) Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study. Circulation 103:102–107

    CAS  PubMed  Google Scholar 

  28. Pinol C, Cobos A, Cases A, Esmatges E, Soler J, Closas J, Pascual R, Planas J (1996) Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria. Kidney Int 49(Suppl 55):S85–S87

    Google Scholar 

  29. Resnik LM (1992) Cellular calcium and magnesium metabolism. The pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med 93(Suppl 2A):11S–20S

    PubMed  Google Scholar 

  30. Rossing P, Hommel E, Smidt UM, Parving HH (1994) Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 45(Suppl 45):S145–S149

    CAS  Google Scholar 

  31. Sahn DJ, De Maria A, Kisslo J, Weyman A (1978) The Committee on M-mode standardization of the American Society of Echocardiography Recommendation regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083

    CAS  PubMed  Google Scholar 

  32. Salvetti A, Mattei P, Sudano I (1999) Renal protection and antihypertensive drugs: current status. Drugs 57:665–693

    CAS  PubMed  Google Scholar 

  33. Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes III, Feinleib M, Castelli WP (1987) The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 75(Suppl 1):I26–I39

    CAS  PubMed  Google Scholar 

  34. Schmieder RE, Schlaich MF, Klingbeil AU, Martus P (1998) Update on reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of all randomized double-blind studies until December 1998. Nephrol Dial Transplant 13:564–569

    CAS  PubMed  Google Scholar 

  35. Scognamiglio R, Nosadini R, Marin M, Nisti S, Fasoli G, Palisi M, Frigato F, Virgili F, Carraro A, Crepaldi G (1997) Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients. Diabetes Care 20:1290–1292

    CAS  PubMed  Google Scholar 

  36. Tenenbaum A, Fisman EZ, Byko V, Goldbourt U, Auerbach I, Shenesh J, Shotan A, Reicher-reiss H, Behar S, Motro M (1999) Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris. Am J Cardiol 84:294–298

    CAS  PubMed  Google Scholar 

  37. United Kingdom Prospective Diabetes Study (UKPDS) Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 317:703–713

    PubMed  Google Scholar 

  38. Valmadrid CT, Klein R, Moss SE, Klein BE (2000) The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160:1093–1100

    CAS  PubMed  Google Scholar 

  39. Weidman P, Boehlen LM, De Courten M, Ferrari P (1992) Antihypertensive therapy in diabetic patients. J Hum Hypertens 6(Suppl 2):S23–S36

    PubMed  Google Scholar 

  40. Zats R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner B (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930

    PubMed  Google Scholar 

  41. 2003 European Society of Hypertension—European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens 21:1011–1053

Download references

Acknowledgements

The present study was carried out with the funds of the Hypertension Centre—University of Pavia. No external financial support was provided.

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Therapeutics, Clinica Medica II, University of Pavia, IRCCS Policlinico S. Matteo, 27100, Pavia, Italy

    Roberto Fogari, Amedeo Mugellini, Annalisa Zoppi, Pierangelo Lazzari, Maurizio Destro, Andrea Rinaldi & Paola Preti

Authors
  1. Roberto Fogari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amedeo Mugellini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Annalisa Zoppi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pierangelo Lazzari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maurizio Destro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrea Rinaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Paola Preti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Fogari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fogari, R., Mugellini, A., Zoppi, A. et al. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. Eur J Clin Pharmacol 61, 483–490 (2005). https://doi.org/10.1007/s00228-005-0961-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-005-0961-2

Keywords

Search

Navigation